Glucagon-like peptide 1 and glucose-dependent insulinotropic peptide hormones and novel receptor agonists protect synapses in Alzheimer’s and Parkinson’s diseases

Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) are peptide hormones and growth factors. A major pathological feature of both Alzheimer’s dis-ease (AD) and Parkinson’s disease (PD) is the loss of synaptic transmission in the cortex in AD and the loss of dopaminergi...

Descripción completa

Detalles Bibliográficos
Autor principal: Hölscher, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363704/
https://www.ncbi.nlm.nih.gov/pubmed/35965783
http://dx.doi.org/10.3389/fnsyn.2022.955258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363704/
https://www.ncbi.nlm.nih.gov/pubmed/35965783
http://dx.doi.org/10.3389/fnsyn.2022.955258

Ejemplares similares